There was another thread on Vitamin K2; but I can't, for the life of me, find it.
Can I ask, are you taking that derivative of K or are you taking K2?
I have been taking the Jarrow brand 90mcg vitamin K-2 (as MK-7) softgel tablets
The menaquinone-7 is the K2, and that is why I chose the particular natto-derived MK-7 K2 supplements I did.
so not to say that it is wrong or bad, but I do wonder about the transferability of this data to the broader population.
Most studies would have much larger groups involved is all...
Obviously a large study in patients on oral anticoagulant treatment is needed to
demonstrate the safety of even low doses of MK-7 in this population.
There was another thread on Vitamin K2; but I can't, for the life of me, find it.
Also, I think this thread:
http://www.valvereplacement.org/forums/showthread.php?37453-Vitamin-K2-and-Warfarin
might be the one where I first saw speculation that K2 might be beneficial for INR stabilization as well as other health benefits.
I tried to be very clear on this in my prior posts.
In my first post I indicated:
I am interested to hear if others with highly volatile INR have seen similar success in reducing the variability of their INR with low-dose vitamin K supplements.
Also, I think this thread:
http://www.valvereplacement.org/foru...2-and-Warfarin
might be the one where I first saw speculation that K2 might be beneficial for INR stabilization as well as other health benefits.
I hope you aren't taking my questions as some sort of personal attack, because they are certainly not intended in that way
this quote:
.......
is from Jarno ... just in case you thought it was me
phew (wipes brow) ... have that problem at work with some folks ... can't handle review. Also it should be mentioned that I got failed in 'tact' ... except in sailing.Good heavens, of course not.
It's just that I get the feeling, since my posts tend to be long and perhaps a bit rambling, that folks were not reading all of what I wrote.
This thread has become quite technical and some of it is above my head.
For me New Mitral is the living proof that the small dose of Vit K2 will not likely cause a dangerous drop in INR.
Jarno
well technical is what I do (so its my mistake to get technical when perhaps its not warranted), and beware of "living proof" as at one stage noone understood why some people require far less warfarin than others ... then we discovered a genetic basis for it.
so what I'm saying is "beware of transferring results"...
.. Last night I read on a post somewhere on the net, that a woman claimed to have had a TIA on this and another thrombosis in her legs.
Further References:
"Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios"
Ford SK, Misita CP, Shilliday BB, Malone RM, Moore CG, Moll S.
Source : Department of Pharmacy, University of North Carolina Hospitals, Chapel Hill, NC 27599, USA.
NIH abstract link: www.ncbi.nlm.nih.gov/pubmed/17323135
Vitamin K supplementation led to a decrease in INR variability in five of the nine patients studied (56%). INR decrease occurred 2-7 days after initiation of vitamin K. Therapeutic INRs were achieved 2-35 days after vitamin K therapy was initiated and an increase in warfarin dose of 6-95% was required to bring the INR back into the therapeutic range
well, sadly that's how it is when we don't have conclusive evidence. ...scientifc studies or what ever information is available, some of it seems to be contradicting
so it will be very hard to draw conclusions.
Most people and even scientific papers seem to be able to prove the point that they want to prove.
while we're trading stamps ...
Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects
After 24 hours of the first new dose, the plasma K1 concentrations had almost completely returned to the previous baseline level, which is consistent with the known rapid plasma clearance of vitamin K.
Natto is known to be a rich source of vitamin K2 (mainly MK-7). At 4 hours after the intake of a single natto meal containing the equivalent of 1 mg (1.54 umol) of MK-7, circulating MK-7 concentrations had risen from undetectable (<0.05 nM) to 13.3 nM, and remained elevated for 7 days......The long plasma half-life time of MK-7 was reflected in a significant decrease of the INR for 7 days.
Enter your email address to join: